Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Awadalkareem Adam, Huanle Luo, Samantha R. Osman, Binbin Wang, Christopher M. Roundy, Albert J. Auguste, Kenneth S. Plante, Bi-Hung Peng, Saravanan Thangamani, Elena I. Frolova, Ilya Frolov, Scott C. Weaver & Tian Wang. (2021) Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models. Emerging Microbes & Infections 10:1, pages 305-316.
Read now
Read now
Manu Goyal, Anil Chauhan, Vishavdeep Goyal, Nishant Jaiswal, Shreya Singh & Meenu Singh. (2018) Recent development in the strategies projected for chikungunya vaccine in humans. Drug Design, Development and Therapy 12, pages 4195-4206.
Read now
Read now
Stanley A. Plotkin. (2017) Vaccines for epidemic infections and the role of CEPI. Human Vaccines & Immunotherapeutics 13:12, pages 2755-2762.
Read now
Read now
Peter Pushko, Igor S. Lukashevich, Scott C. Weaver & Irina Tretyakova. (2016) DNA-launched live-attenuated vaccines for biodefense applications. Expert Review of Vaccines 15:9, pages 1223-1234.
Read now
Read now
Articles from other publishers (40)
Qianlin Li, Jun Dai, Yongxia Shi, Qiang Deng, Conghui Liao, Jicheng Huang & Jiahai Lu. (2024) IgM-specific linear epitopes on the E2 protein for serodiagnosis of Chikungunya. Virus Research 339, pages 199292.
Crossref
Crossref
Vaitiare Mulderij-Jansen, Izzy Gerstenbluth, Ashley Duits, Adriana Tami & Ajay Bailey. (2023) Contexts motivating protective behaviours related to Aedes-borne infectious diseases in Curaçao. BMC Public Health 23:1.
Crossref
Crossref
Jhoana P Romero-Leiton, Kamal Raj Acharya, Jane Elizabeth Parmley, Julien Arino & Bouchra Nasri. (2023) Modelling the transmission of dengue, zika and chikungunya: a scoping review protocol. BMJ Open 13:9, pages e074385.
Crossref
Crossref
Deepika Rani, Madan Kaushik & Ranjit Singh. (2023) EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF CHIKUNGUNYA - A REVIEW. INDIAN DRUGS 60:07, pages 7-15.
Crossref
Crossref
Benjamin Panzer, Christoph W. Kopp, Christoph Neumayer, Renate Koppensteiner, Alicja Jozkowicz, Michael Poledniczek, Thomas Gremmel, Bernd Jilma & Patricia P. Wadowski. (2023) Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review. Cells 12:14, pages 1865.
Crossref
Crossref
Akhil Maheshwari, Mario Motta & Kei Lui. (2023) Editorial. Newborn 2:1, pages iv-vii.
Crossref
Crossref
H.J.A. Fleury. 2023. Virus émergents et Ré-émergents. Virus émergents et Ré-émergents
159
164
.
Doris K. Nyamwaya, Samuel M. Thumbi, Philip Bejon, George M. Warimwe & Jolynne Mokaya. (2022) The global burden of Chikungunya fever among children: A systematic literature review and meta-analysis. PLOS Global Public Health 2:12, pages e0000914.
Crossref
Crossref
Merhawi Debesai Oqbazgi. 2022. Chikungunya Virus - A Growing Global Public Health Threat. Chikungunya Virus - A Growing Global Public Health Threat.
Manisha Shukla, Pankaj Chandley, Suman Tapryal, Narendra Kumar, Sulakshana P. Mukherjee & Soma Rohatgi. (2022) Expression, Purification, and Refolding of Chikungunya Virus Full-Length Envelope E2 Protein along with B-Cell and T-Cell Epitope Analyses Using Immuno-Informatics Approaches. ACS Omega 7:4, pages 3491-3513.
Crossref
Crossref
Maheshi Mapalagamage, Daniela Weiskopf, Alessandro Sette & Aruna Dharshan De Silva. (2022) Current Understanding of the Role of T Cells in Chikungunya, Dengue and Zika Infections. Viruses 14:2, pages 242.
Crossref
Crossref
Allison August, Husain Z. Attarwala, Sunny Himansu, Shiva Kalidindi, Sophia Lu, Rolando Pajon, Shu Han, Jean-Michel Lecerf, Joanne E. Tomassini, Marjie Hard, Leon M. Ptaszek, James E. Crowe & Tal Zaks. (2021) A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nature Medicine 27:12, pages 2224-2233.
Crossref
Crossref
Jonathan O. Rayner, Jin Hyun Kim, Rosemary W. Roberts, Raphael Ryan Wood, Brian Fouty & Victor Solodushko. (2021) Evaluation of DNA-Launched Virus-Like Particle Vaccines in an Immune Competent Mouse Model of Chikungunya Virus Infection. Vaccines 9:4, pages 345.
Crossref
Crossref
Patricia P. Wadowski, Bernd Jilma, Christoph W. Kopp, Sebastian Ertl, Thomas Gremmel & Renate Koppensteiner. (2021) Glycocalyx as Possible Limiting Factor in COVID-19. Frontiers in Immunology 12.
Crossref
Crossref
Jessamine E. Hazlewood, Troy Dumenil, Thuy T. Le, Andrii Slonchak, Stephen H. Kazakoff, Ann-Marie Patch, Lesley-Ann Gray, Paul M. Howley, Liang Liu, John D. Hayball, Kexin Yan, Daniel J. Rawle, Natalie A. Prow & Andreas Suhrbier. (2021) Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures. PLOS Pathogens 17:1, pages e1009215.
Crossref
Crossref
Sandeep Kumar, Vikas Kumar Singh, Manohar Vasam, Poonam Shewale Patil, Rajeev K. Dhaked, Abdul S. Ansari, Nirmal K. Lohiya, Deepti Parashar & Suman Tapryal. (2020) An in vitro refolding method to produce oligomers of anti-CHIKV, E2-IgM Fc fusion subunit vaccine candidates expressed in E. coli. Journal of Immunological Methods 487, pages 112869.
Crossref
Crossref
Francisco Collantes, Manuel José Méndez, Caridad Soto-Castejón & Eva María Muelas. (2020) Consolidation of Aedes albopictus Surveillance Program in the Autonomous Community of the Region of Murcia, Spain. International Journal of Environmental Research and Public Health 17:11, pages 4173.
Crossref
Crossref
Vaitiare Mulderij-Jansen, Jelte Elsinga, Izzy Gerstenbluth, Ashley Duits, Adriana Tami & Ajay Bailey. (2020) Understanding risk communication for prevention and control of vector-borne diseases: A mixed-method study in Curaçao. PLOS Neglected Tropical Diseases 14:4, pages e0008136.
Crossref
Crossref
Adekunle Sanyaolu, Oladapo Ayodele, Lorena Likaj, Aleksandra Marinkovic, Jennifer Locke, Miriam Ahmed, Odunayo Akanbi, Verner Orish, Chuku Okorie & Olanrewaju Badaru. (2019) Changing Epidemiology, Treatment, and Vaccine Update on Chikungunya, Dengue, and Zika Viruses. Current Tropical Medicine Reports 6:3, pages 145-159.
Crossref
Crossref
John F. Honek. (2019) Commentary on “Current Challenges in the Development of Vaccines and Drugs Against Emerging Vector-borne Diseases” by Professor Kwang-sun Kim, Pusan National University, Republic of Korea. Current Medicinal Chemistry 26:17, pages 3201-3204.
Crossref
Crossref
Kwang-sun Kim. (2019) Current Challenges in the Development of Vaccines and Drugs Against Emerging Vector-borne Diseases. Current Medicinal Chemistry 26:16, pages 2974-2986.
Crossref
Crossref
Siva Raghavendhar, Praveen Kumar Tripati, Pratima Ray & Ashok Kumar Patel. (2019) Evaluation of medicinal herbs for Anti-CHIKV activity.. Virology 533, pages 45-49.
Crossref
Crossref
Stanley A Plotkin. (2019) Chikungunya Virus: A Back-Breaking Problem. Journal of the Pediatric Infectious Diseases Society 8:2, pages 95-96.
Crossref
Crossref
Gérald Theillet, Jérôme Martinez, Christophe Steinbrugger, Dimitri Lavillette, Bruno Coutard, Nicolas Papageorgiou, Pascal Dalbon, Isabelle Leparc-Goffart & Frédéric Bedin. (2019) Comparative study of chikungunya Virus-Like Particles and Pseudotyped-Particles used for serological detection of specific immunoglobulin M. Virology 529, pages 195-204.
Crossref
Crossref
K. V. Zhukov, A. V. Toporkov & D. V. Viktorov. (2018) EPIDEMIOLOGICAL ASPECTS AND MODERN EVOLUTION OF GLOBALLY SPREADING ARBOVIRUSES. Journal of microbiology, epidemiology and immunobiology 95:6, pages 94-102.
Crossref
Crossref
Emil C Reisinger, Roland Tschismarov, Eckhard Beubler, Ursula Wiedermann, Christa Firbas, Micha Loebermann, Andrea Pfeiffer, Matthias Muellner, Erich Tauber & Katrin Ramsauer. (2018) Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. The Lancet 392:10165, pages 2718-2727.
Crossref
Crossref
Hobart Lee, Sara Halverson & Ngozi Ezinwa. (2018) Mosquito-Borne Diseases. Primary Care: Clinics in Office Practice 45:3, pages 393-407.
Crossref
Crossref
Aruna Narula, Rajan Kumar Pandey, Nazia Khatoon, Amit Mishra & Vijay Kumar Prajapati. (2018) Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection. Infection, Genetics and Evolution 61, pages 4-15.
Crossref
Crossref
Rana Abdelnabi, Dirk Jochmans, Erik Verbeken, Johan Neyts & Leen Delang. (2018) Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection. Antiviral Research 149, pages 113-117.
Crossref
Crossref
Sanjeev K. Handique & Mausumi Barthakur. 2018. CNS Infections. CNS Infections
87
128
.
Chris M. Cirimotich, Eric M. Vela, Jennifer Garver, Roy E. Barnewall, Brian D. Miller, Gabriel T. Meister & James V. Rogers. (2017) Chikungunya virus infection in Cynomolgus macaques following Intradermal and aerosol exposure. Virology Journal 14:1.
Crossref
Crossref
Cecilia Gómez-Calderón, Carol Mesa-Castro, Sara Robledo, Sergio Gómez, Santiago Bolivar-Avila, Fredyc Diaz-Castillo & Marlen Martínez-Gutierrez. (2017) Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections. BMC Complementary and Alternative Medicine 17:1.
Crossref
Crossref
Wenxi An, Ningning Ge, Yilin Cao, Jin Sun & Xia Jin. (2017) Recent progress on chikungunya virus research. Virologica Sinica 32:6, pages 441-453.
Crossref
Crossref
Jeng-Wei Lu, Po-Shiuan Hsieh, Chang-Chi Lin, Ming-Kuan Hu, Shih-Ming Huang, Yu-Ming Wang, Chun-Yu Liang, Zhiyuan Gong & Yi-Jung Ho. (2017) Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus. Biochemical and Biophysical Research Communications 491:3, pages 595-602.
Crossref
Crossref
Laurie A. Silva & Terence S. Dermody. (2017) Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. Journal of Clinical Investigation 127:3, pages 737-749.
Crossref
Crossref
Michael R. Yeaman & John P. HennesseyJr.Jr.. (2017) Innovative Approaches to Improve Anti-Infective Vaccine Efficacy. Annual Review of Pharmacology and Toxicology 57:1, pages 189-222.
Crossref
Crossref
Marc P. Girard. (2016) Arboviroses et fièvres hémorragiques : actualités épidémiologique et vaccinale. Bulletin de l'Académie Nationale de Médecine 200:8-9, pages 1617-1630.
Crossref
Crossref
Eva Torres-Sangiao, Alina Holban & Monica Gestal. (2016) Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases. Molecules 21:7, pages 867.
Crossref
Crossref
Sarah L. Rowland-Jones. (2016) Chikungunya: out of the tropical forests and heading our way …. Transactions of The Royal Society of Tropical Medicine and Hygiene 110:2, pages 85-86.
Crossref
Crossref
S.A. Gray, R.N. Coler, D. Carter & A.A. Siddiqui. 2016. Host-Microbe Interactions. Host-Microbe Interactions
291
315
.